« previous next »
Pages: [1]   Go Down

Author Topic: Sanofi-Aventis Wants F.D.A. to Reconsider Heart Drug  (Read 885 times)

0 Members and 2 Guests are viewing this topic.

Offline feedbot

  • Επίλεκτο μέλος
  • *****
  • Posts: 6686
  • Κάπνισμα: Δεν κάπνισα ποτέ
Sanofi-Aventis Wants F.D.A. to Reconsider Heart Drug
« on: 16 May, 2008, 11:00:08 »
Sanofi-Aventis Wants F.D.A. to Reconsider Heart Drug
     

The company said it would resubmit its application for Multaq based on results from a study showing that the drug reduced both hospitalization and death in patients with atrial fibrillation.<br/><br/>    <a href="http://www.pheedo.com/click.phdo?x=07ef2180cee44d9abb689f9f7fe272d1&u=http://www.nytimes.com/2008/05/16/business/16drug.html"><img src="http://www.pheedo.com/img.phdo?x=07ef2180cee44d9abb689f9f7fe272d1&u=http://www.nytimes.com/2008/05/16/business/16drug.html" border="0"/></a>

     

http://www.nytimes.com/2008/05/16/business/16drug.html?partner=rssnyt&emc=rss
     
Logged
Pages: [1]   Go Up
« previous next »
 

Cookies help us provide you a better browsing experience. By using our site, you consent to the use of cookies by us.